The role of ferroptosis in osteoporosis: from pathogenic mechanisms to natural product-driven therapeutic innovations. [PDF]
Zhu Y, Wu X, Peng X, He H, Hu Z, Xiao L.
europepmc +1 more source
Fragmented QRS duration as a marker of cardiac and hepatic iron overload: across-sectional study. [PDF]
Hedayati SB +4 more
europepmc +1 more source
A role for deferasirox as an anti-neoplastic and chemosensitising agent in gastrointestinal cancer [PDF]
Matthew Bedford
openalex
Transmetalation in Cancer Pharmacology. [PDF]
Dharmasivam M, Kaya B.
europepmc +1 more source
A case/non-case study of a national pharmacovigilance database to explore drug-induced acute kidney injury. [PDF]
Oliveira CL +4 more
europepmc +1 more source
The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with antifungal agents. [PDF]
Tóth Z +7 more
europepmc +1 more source
Exploration of novel triazolo-thiadiazine hybrids of deferasirox as multi-target-directed anti-neuroinflammatory agents with structure-activity relationship (SAR): a new treatment opportunity for Alzheimer's disease. [PDF]
Shakir SA +10 more
europepmc +1 more source
Deferasirox Targets TAOK1 to Induce p53-Mediated Apoptosis in Esophageal Squamous Cell Carcinoma. [PDF]
Li B +7 more
europepmc +1 more source
Alterations in iron status predict cardiac response to blood transfusion in β-thalassemia major. [PDF]
Ricci A +11 more
europepmc +1 more source

